Paul A. Friedman M.D.
Net Worth

Last updated:

What is Paul A. Friedman M.D. net worth?

The estimated net worth of Dr. Paul A. Friedman M.D. is at least $124,586,060 as of 8 Apr 2024. He owns shares worth $71,507,975 as insider, has earned $45,588,085 from insider trading and has received compensation worth at least $7,490,000 in Madrigal Pharmaceuticals, Inc..

What is the salary of Paul A. Friedman M.D.?

Dr. Paul A. Friedman M.D. salary is $1,070,000 per year as Chairman & Chief Executive Officer in Madrigal Pharmaceuticals, Inc..

How old is Paul A. Friedman M.D.?

Dr. Paul A. Friedman M.D. is 82 years old, born in 1943.

What stocks does Paul A. Friedman M.D. currently own?

As insider, Dr. Paul A. Friedman M.D. owns shares in one company:

Company Title Shares Price per share Total value
Madrigal Pharmaceuticals, Inc. (MDGL) Chairman & Chief Executive Officer 185,735 $385 $71,507,975

What does Madrigal Pharmaceuticals, Inc. do?

Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III clinical trials for the treatment of non-alcoholic steatohepatitis. The company also develops MGL-3745, a backup compound to resmetirom. It has research, development, and commercialization agreement with Hoffmann-La Roche. Madrigal Pharmaceuticals, Inc. is headquartered in West Conshohocken, Pennsylvania.

MDGL logo
MDGL
Madrigal Pharmaceuticals, Inc.
$385

Paul A. Friedman M.D. insider trading

Madrigal Pharmaceuticals, Inc.

Dr. Paul A. Friedman M.D. has made 28 insider trades between 2018-2024, according to the Form 4 filled with the SEC. Most recently he sold 5,663 units of MDGL stock worth $1,386,648 on 8 Apr 2024.

The largest trade he's ever made was exercising 73,526 units of MDGL stock on 11 Jun 2018. As of 8 Apr 2024 he still owns at least 185,735 units of MDGL stock.

Transaction Date Security Shares Price per share Total value Source
Sale
Common Stock 5,663 $244.86 $1,386,648
Sale
Common Stock 3,464 $247.76 $858,241
Option
Stock Option (Right to Buy) 26,270 $9.45 $248,251
Sale
Common Stock 1,441 $242.95 $350,094
Sale
Common Stock 5,028 $246.96 $1,241,710
Sale
Common Stock 3,730 $244.12 $910,568
Sale
Common Stock 2,078 $245.71 $510,592
Option
Common Stock 26,270 $9.45 $248,251
Sale
Common Stock 4,866 $248.59 $1,209,644
Sale
Common Stock 5,228 $245.35 $1,282,669
Sale
Common Stock 6,679 $242.42 $1,619,096
Option
Common Stock 27,613 $9.45 $260,943
Sale
Common Stock 612 $241.15 $147,583
Sale
Common Stock 3,966 $244.22 $968,588
Sale
Common Stock 444 $245.92 $109,189
Option
Stock Option (Right to Buy) 27,613 $9.45 $260,943
Sale
Common Stock 9,264 $243.2 $2,253,014
Sale
Common Stock 1,420 $240.1 $340,939
Option
Common Stock 18,710 $9.45 $176,810
Option
Stock Option (Right to Buy) 18,710 $9.45 $176,810
Sale
Common Stock 200 $248.43 $49,685
Sale
Common Stock 737 $247.14 $182,141
Sale
Common Stock 1,558 $246.13 $383,471
Sale
Common Stock 2,549 $245.14 $624,857
Sale
Common Stock 627 $244.31 $153,185
Sale
Common Stock 1,467 $243 $356,482
Sale
Common Stock 5,299 $242.25 $1,283,677
Sale
Common Stock 6,273 $241.07 $1,512,220
Sale
Common Stock 18,806 $245.34 $4,613,826
Sale
Common Stock 1,821 $246.31 $448,531
Sale
Common Stock 4,301 $244.59 $1,051,960
Option
Stock Option (Right to Buy) 27,407 $9.45 $258,996
Option
Common Stock 27,407 $9.45 $258,996
Sale
Common Stock 185 $242 $44,770
Sale
Common Stock 2,294 $243.65 $558,922
Purchase
Common Stock 4,000 $117.88 $471,520
Purchase
Common Stock 4,000 $124 $496,000
Sale
Common Stock 73,526 $287.46 $21,135,784

Madrigal Pharmaceuticals key executives

Madrigal Pharmaceuticals, Inc. executives and other stock owners filed with the SEC: